International Flavors & Fragrances Inc.
IFF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$20.32B
Close$
Earnings Call Q3 2026
November 4, 2026 - AI Summary
Strong Q3 performance + improved profitability (all continuing ops)
- Revenue in Q3: ~$2.0B, up ~5% on a currency-neutral comparable basis, driven by volume and new wins.
- EBITDA: $403M, up 6%; EBITDA margin: 20.8%, up +20 bps (currency-neutral comparable).
- Segment highlights: Taste +6% sales to $687M; Scent +6% to $689M; Health & Biosciences +1% to $566M (health softer).
Raised full-year guidance (despite macro uncertainty)
- Company raised the lower end of full-year ranges based on year-to-date momentum:
- Sales: ~$7.5B–$7.6B
- Adjusted operating EBITDA: $1.55B–$1.6B
- Q4 expectations: continued sales growth (volume-led), but profitability margin moderates sequentially.
- Key reason for Q4 margin pressure: Health & Biosciences profitability softness plus higher costs/investments (including seasonality—Q4 is historically the lowest margin quarter).
Health & Biosciences is the main drag—turnaround underway but market is soft
- Management attributed slower Health growth to a challenged supplement end-market (US/Europe consumers reducing discretionary spending).
- Turnaround actions: strengthen commercial capabilities, diversify customer base, work with customers to communicate clinically proven benefits, and advance the innovation pipeline (example: new product GUT-X with strong initial customer interest).
- Outlook impact: Health softness expected to persist into Q4, and 2027 expectations hinge on market recovery + execution.
Exclusive for Stockcircle Pro members
Sign up
$6.75
91.7% downside
Current Fair Value
91.7% downsideOvervalued by 91.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $20.32 Billion |
|---|---|
| Enterprise Value | $26.84 Billion |
| Annual dividend | $1.60 |
| Dividend yield | 1.97% |
| Earnings per Share | $-1.46 |
| Beta | 0.88 |
| Outstanding Shares | 253,000,000 |
Return
| Return on Equity | 1.37% |
|---|---|
| Return on Assets | 0.73% |
| Return on Invested Capital | 1.97% |
Valuation & Multiples
| P/E Ratio | 106.79 |
|---|---|
| PEG | -44.96 |
| Price to Sales | 2.25 |
| Price to Book Ratio | 1.56 |
| Enterprise Value to Revenue | 2.91 |
| Enterprise Value to EBIT | 68.48 |
| Enterprise Value to Net Income | 147 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 0.51 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 3, 2026
EPS
$0.83
Est. $0.81Revenue
$1.94 B
Est. $1.91 BNext Earnings Call
Expected Date
February 10, 2027
EPS Estimate
$0.63
Consensus analyst estimateRevenue Estimate
$1.82 B
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 59.67% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 23.81%▼ 83.07% |
|---|---|
| Total Invested | $5.09B▼ 76.54% |
| Investors Holding | 376▼ 397.00% |
About International Flavors & Fragrances Inc.
13,600 employees
CEO: Andreas Fibig
IFF uses Uncommon Sense to create what the world needs. As a collective of unconventional thinkers and creators, the Company puts science and artistry to work to create unique and unexpected scents, tastes, experiences and ingredients for the products its world craves.